SATURDAY, 1st OCTOBER
OVERWHELMING INFLAMMATORY DISEASES
Chairs: A. Giarratano; A. Pesenti
Extracorporeal Therapies and Antibiotics Management
F. Aucella
The Pediatric experience and the CytoPed Study
G. Bottari
What our 400 patients tell us
M. Pieri; A. M. Scandroglio
Chairs: M. Ranieri; C. Ronco
Introductory Lecture
J. L. Vincent
Dispute
Are Extracorporeal Therapies useful for
septic patients?
Cons L. Gattinoni
Pros C. Ince
Discussion
Chairs: F. Aucella; L. Gottin
Chairs: F. Fabretti; S. Faenza
Lecture: Extracorporeal Purification and Liver
S. Mitzner
Extracorporeal therapies face to face
I. Riva
The Biliver Study
A. Siniscalchi
Discussion
Chairs: G. Berlot; A. Donati
Lecture: Biomarkers dream or reality?
P. Caironi
PSP and the diagnosis of sepsis
J. Pereira
PSP and diagnosis in Covid 19
G. Castellano
Discussion